Further, CXCR4 expressing CAR-NK cells exhibited an enhanced ability to migrate towards a CCL12 gradient while maintaining functional cytolytic activity towards target cancer cells (CD19+ Nalm-6 cells) in vitro (126). This evidence concerns the gene CXCR4 and cancer.